Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. DFTX
9. HOOD
10. IBM

Go back to Xilio Therapeutics Announces New Preclinical Data at AACR Annual Meeting for XTX601, a Masked T Cell Engager Targeting CLDN18.2
(NASDAQ: XLO) Delayed: 8.94 +0.15 (1.71%)
Previous Close $8.79    52 Week High $ 
Open $8.99    52 Week Low $ 
Day High $9.05    P/E N/A 
Day Low $8.83    EPS $ 
Volume 26,154